Constantin G Ioannides

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: The University of Texas System, The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Health Research, Inc.. Active years: 1995-2019.

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 44.4

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 56(Granted Patents)

Company Filing History:

7 out of 5,633

The University of Texas System

patents

6 out of 196

The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.

patents

1 out of 313

Health Research, Inc.

patents

where one patent can have more than one assignee

Years Active: 1995-2019

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10239916 - Controlled modulation of amino acid side chain length of peptide antigens (2019-03-26),

2. 9562070 - Induction of tumor immunity by variants of folate binding protein (2017-02-07),

3. 8815256 - Induction of tumor immunity by variants of folate binding protein (2014-08-26),

4. 8802618 - Controlled modulation of amino acid side chain length of peptide antigens (2014-08-12),

5. 8258261 - Induction of tumor immunity by variants of folate binding protein (2012-09-04),

6. 7547759 - Induction of tumor immunity by variants of folate binding protein (2009-06-16),

7. 7348153 - Method for identifying and designing immunogenic peptides (2008-03-25),

8. 6514942 - Methods and compositions for stimulating T-lymphocytes (2003-02-04),

9. 5434076 - Tumor-specific, cell surface-binding monoclonal antibodies (1995-07-18),

Title: Constantin G Ioannides: A Trailblazer in Innovation

Introduction:

Constantin G Ioannides, a visionary inventor based in Houston, TX, has been at the forefront of transformative innovation, dedicated to creating solutions that shape a brighter future through his relentless pursuit of groundbreaking inventions.

Latest Patents:

With an impressive portfolio of 9 patents, Constantin's latest inventions are revolutionizing the field of medicine. One of his patents involves the controlled modulation of amino acid side chains in peptide antigens, enhancing immunogenicity while minimizing cross-reactivity. Another patent focuses on inducing tumor immunity through variants of folate binding protein epitopes.

Career Highlights:

Constantin's career is marked by significant contributions to the realms of science and technology. He has made invaluable strides in advancing military medicine through his work with The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., as well as in the academic sector with the University of Texas System.

Collaborations:

Collaborating with esteemed professionals such as George E Peoples and Martin L Campbell, Constantin has fostered a culture of innovation and excellence. Together, they have worked towards developing cutting-edge solutions that have the potential to revolutionize healthcare and biotechnology.

Conclusion:

Constantin G Ioannides continues to be a driving force in the world of innovation, showcasing an unwavering commitment to pushing boundaries and creating solutions that have a profound impact on society. His groundbreaking patents and collaborative spirit underscore his dedication to shaping a better future through inventive thinking and transformative inventions.